SEC Form 4 · accession 0001437749-18-010050
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Durbin
Officer — Chief Executive Officer · Director
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 7:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Purchase)F1 | $1.97 | May 11, 2018 | A | 300,000 | A | — | May 10, 2028 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The Reporting Person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 300,000 stock options (the "Grant") on May 11, 2018. The Grant shall vest as follows: 25% of the stock options subject to the Grant shall vest on May 10, 2019 and 1/48th of the stock options subject to the Grant shall vest in equal monthly installments thereafter subject to the Reporting Person's continued service to the Issuer through each vesting date.